VCAM1 and major depressive disorder: Regarding the influence of SSRIs on vascular endothelial function, some studies have found that during treatment with escitalopram, the levels of biomarkers of vascular endothelial dysfunction, such as soluble von Willebrand factor (sVWF) and vascular cell adhesion molecule-1(VCAM-1), gradually decrease in patients with major depression (60).